My bookmarksSign up free

Commission Implementing Regulation (EU) 2021/52 of 22 January 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin (Text with EEA relevance)

Commission Implementing Regulation (EU) 2021/52 of 22 January 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin (Text with EEA relevance)

Implementing Regulation (EU) 2021/52 Β· Regulation Β· 3 articles

Data as of 2026-07-04 Β· Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. Β· Read the official text β†—

Article 1

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

ANNEX Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 57, Mecoprop-P, the date is replaced by β€˜31 January 2022’; (2) in the sixth column, expiration of approval, of row 81, Pyraclostrobin, the date is replaced by β€˜31 January 2022’; (3) in the sixth column, expiration of approval, of row 115, Metiram, the date is replaced by β€˜31 January 2022’; (4) in the sixth column, expiration of approval, of row 116, Oxamyl, the date is replaced by β€˜31 January 2022’; (5) in the sixth column, expiration of approval, of row 128, Dimoxystrobin, the date is replaced by β€˜31 January 2022’; (6) in the sixth column, expiration of approval, of row 187, Flutolanil, the date is replaced by β€˜28 February 2022’; (7) in the sixth column, expiration of approval, of row 188, Benfluralin, the date is replaced by β€˜28 February 2022’; (8) in the sixth column, expiration of approval, of row 189, Fluazinam, the date is replaced by β€˜28 February 2022’; (9) in the sixth column, expiration of approval, of row 191, Mepiquat, the date is replaced by β€˜28 February 2022’.

Source: EUR-Lex (Publications Office of the EU), Β© European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next